Quarterly report [Sections 13 or 15(d)]

NET LOSS PER SHARE - Schedule of Diluted Shares Outstanding (Details)

v3.26.1
NET LOSS PER SHARE - Schedule of Diluted Shares Outstanding (Details) - shares
 3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Backstop Notes | Senior Notes    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Percentage of common stock outstanding, issuable 9.90%  
Common stock issuable due to grants of RSUs with service only (i.e., time-vesting) conditions    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Antidilutive securities excluded from computation of earnings per share (in shares) 1,086,361 882,886
Common stock issuable on conversion of the Backstop Notes    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Antidilutive securities excluded from computation of earnings per share (in shares) 1,920,007 1,920,007
Common stock issuable on exercise of private placement warrants    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Antidilutive securities excluded from computation of earnings per share (in shares) 54,556 54,556